https://www.selleckchem.com/products/cx-5461.html
The current kidney allocation system (KAS) preferentially allocates kidneys from blood type A2 or A2B (A/A2 donors to blood type B candidates. We used national data to evaluate center-level performance of A2/A2B to B transplants, and organ procurement organization (OPO) reporting of type A or AB donor subtyping, in 5-year time periods prior to (2009-2014) and following (2015-2019) KAS implementation. The number of centers performing A2/A2B to B transplants increased from 17 pre-KAS to 76 post-KAS, though this still represents only a m
Gefällt mir
Kommentar
Teilen
